Arcline-Backed Arxis Announces Pricing of its Initial Public Offering

Rhea-AI Summary

Arxis (NASDAQ:ARXS) priced an upsized initial public offering of 40,500,000 Class A shares at $28.00 per share, with a 30-day underwriter option for up to 6,075,000 additional shares. Trading is expected to begin on the Nasdaq Global Select Market on April 16, 2026, with closing targeted for April 17, 2026, subject to customary closing conditions.

Arxis filed a registration statement on Form S-1 that was declared effective on April 15, 2026. Lead joint book-runners include Goldman Sachs, Morgan Stanley and Jefferies.

Positive

• Upsized IPO of 40,500,000 shares priced at $28.00
• Underwriters granted 30-day option for 6,075,000 additional shares
• Expected Nasdaq listing on April 16, 2026

Negative

• Closing subject to customary conditions; close expected April 17, 2026
• Potential additional dilution from 6,075,000-share underwriters option

Market Context

This announcement detailed the pricing of Arxis’s IPO, with 40,500,000 shares offered at $28.00 per ...

Analysis

This announcement detailed the pricing of Arxis’s IPO, with 40,500,000 shares offered at $28.00 per share and a 30-day option for 6,075,000 additional shares. Trading was expected to begin on Nasdaq under "ARXS" on April 16, 2026, following the SEC’s effectiveness of the Form S-1 on April 15, 2026. Investors may focus on execution of growth plans, capital allocation, and future filings as key metrics to watch.

Key Figures

IPO shares offered: 40,500,000 shares IPO price: $28.00 per share Underwriters' option shares: 6,075,000 shares +5 more

8 metrics

IPO shares offered 40,500,000 shares Upsized initial public offering

IPO price $28.00 per share Public offering price

Underwriters' option shares 6,075,000 shares 30-day option for additional shares

Underwriters' option period 30 days Option to purchase additional shares

S-1 effective date April 15, 2026 Form S-1 declared effective by SEC

Expected trading start April 16, 2026 Nasdaq Global Select Market, symbol "ARXS"

Expected offering close April 17, 2026 Subject to customary closing conditions

Registration form Form S-1 Registration statement filed with the SEC

Key Terms

initial public offering, prospectus, form s-1

3 terms

initial public offering financial

"announced today the pricing of its upsized initial public offering of 40,500,000"

An initial public offering (IPO) is when a private company first sells its shares to the public and becomes a stock-listed company. It matters because it allows the company to raise money from a wide range of investors, helping it grow, while giving early shareholders a way to sell some of their ownership.

prospectus regulatory

"The offering is being made only by means of a prospectus. Copies of the prospectus"

A prospectus is a detailed document that explains a company's plans for offering new shares or investments to the public. It’s important because it provides potential investors with key information about the company’s business, risks, and how they might make money, helping them decide whether to invest. Think of it as a guidebook for understanding what you're buying into.

form s-1 regulatory

"A registration statement on Form S-1 relating to the offering has been filed"

A Form S-1 is the registration filing a company submits to the U.S. Securities and Exchange Commission when it plans to offer stock to the public, most commonly for an initial public offering. Think of it as the company’s full disclosure packet or blueprint: it contains audited financials, business description, management background, risk factors and details of the offering, giving investors the information needed to judge the company’s financial health and potential risks before buying shares.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

BLOOMFIELD, Conn., April 15, 2026 /PRNewswire/ -- Arxis, Inc. ("Arxis"), a portfolio company of Arcline Investment Management and a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical engineered components, announced today the pricing of its upsized initial public offering of 40,500,000 shares of Class A common stock (the "Shares"), offered by Arxis at a public offering price of $28.00 per share. In addition, Arxis has granted the underwriters a 30-day option to purchase up to 6,075,000 additional shares at the public offering price, less underwriting discounts and commissions. The Shares are expected to begin trading on the Nasdaq Global Select Market on April 16, 2026, under the symbol "ARXS."

The closing of the offering is expected to occur on April 17, 2026, subject to the satisfaction of customary closing conditions.

Goldman Sachs & Co. LLC, Morgan Stanley and Jefferies are acting as lead joint book-running managers for the offering.

Citigroup and RBC Capital Markets are acting as joint book-running managers, and Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, and Wolfe | Nomura Alliance are acting as book-running managers.

Citizens Capital Markets is acting as a co-manager.

A registration statement on Form S-1 relating to the offering has been filed with the U.S. Securities and Exchange Commission (the "SEC") and was declared effective on April 15, 2026. The offering is being made only by means of a prospectus. Copies of the prospectus relating to the offering may be obtained for free by visiting EDGAR on the SEC's website at www.sec.gov. Alternatively, copies of the prospectus may be obtained from Goldman Sachs & Co. LLC, Attention: Prospectus Department, 200 West Street, New York, NY 10282, by telephone at 866-471-2526 or by email at prospectus-ny@ny.email.gs.com; Morgan Stanley & Co. LLC, Attention: Prospectus Department, 180 Varick Street, 2nd Floor, New York, NY 10014; or Jefferies LLC, Attention: Equity Syndicate Prospectus Department, 520 Madison Avenue, New York, New York 10022, by telephone at (877) 821-7388 or by email at Prospectus_Department@Jefferies.com.

This press release does not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sale of these securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such state or jurisdiction. Any offers, solicitations or offers to buy, or any sales of securities will be made in accordance with the registration requirements of the Securities Act of 1933, as amended.

"Wolfe | Nomura Alliance" is the marketing name used by Wolfe Research Securities and Nomura Securities International, Inc. in connection with certain equity capital markets activities conducted jointly by the firms. Both Nomura Securities International, Inc. and WR Securities, LLC are serving as underwriters in the offering described herein. In addition, WR Securities, LLC and certain of its affiliates may provide sales support services, investor feedback, investor education, and/or other independent equity research services in connection with this offering.

About Arxis
Arxis is a leading designer and manufacturer of proprietary, mission-critical electronic and mechanical components for aerospace and defense, medical technology, and specialized industrial markets. Leveraging significant intellectual property and world-class engineering and operational capabilities, Arxis designs and delivers innovative solutions that address our customers' most complex performance needs.

Media Contacts
Kate Thompson / Tim Ragones / Alexander Wolfsohn
Joele Frank, Wilkinson Brimmer Katcher
(212) 355-4449

View original content:https://www.prnewswire.com/news-releases/arcline-backed-arxis-announces-pricing-of-its-initial-public-offering-302743924.html

SOURCE Arxis

FAQ

How many shares did Arxis (ARXS) price in its April 16, 2026 IPO?

Arxis priced an upsized IPO of 40,500,000 Class A shares at $28.00 per share. According to the company, underwriters also have a 30-day option to purchase up to 6,075,000 additional shares.

When will ARXS begin trading on Nasdaq and what is the ticker?

ARXS is expected to begin trading on the Nasdaq Global Select Market on April 16, 2026 under the ticker ARXS. According to the company, the offering closing is expected on April 17, 2026, subject to customary conditions.

Who are the lead underwriters for Arxis's (ARXS) IPO?

Goldman Sachs, Morgan Stanley and Jefferies are the lead joint book-running managers for the offering. According to the company, Citigroup, RBC, Baird and others are also participating as managers and co-managers.

What filing made Arxis's (ARXS) IPO effective and when?

A registration statement on Form S-1 relating to the offering was declared effective on April 15, 2026. According to the company, the offering is being made only by means of a prospectus available via EDGAR.

What is the underwriter overallotment for Arxis (ARXS) and why does it matter?

Underwriters have a 30-day option to buy up to 6,075,000 additional shares at the offering price. According to the company, this option can increase the total shares sold and affect post-offer share count.

When is the expected closing date for the ARXS IPO and are there conditions?

The closing of the offering is expected to occur on April 17, 2026, subject to customary closing conditions. According to the company, completion depends on satisfaction of those customary closing conditions.